tiprankstipranks
Trending News
More News >
Inhibikase Therapeutics (IKT)
NASDAQ:IKT

Inhibikase Therapeutics (IKT) Market Cap & Net Worth

Compare
380 Followers

Inhibikase Therapeutics Market Cap

Inhibikase Therapeutics has a market cap or net worth of $237.68M as of Mar 19, 2026. Its market cap has increase by 38.73% in one year.
Market Cap
$237.68M
Enterprise Value
$100.90M
1-Year Change
38.73%
Category
Micro (Under 300M)
Stock Price
$1.96

Market Cap Chart

Market Cap History
Date
Market Cap
% Change
Mar 17, 2026
139.17M-1.01%
Mar 16, 2026
140.59M-1.00%
Mar 13, 2026
142.01M+0.50%
Mar 12, 2026
141.30M-1.49%
Mar 11, 2026
143.43M+3.59%
Mar 10, 2026
138.46M+3.17%
Mar 09, 2026
134.20M+0.53%
Mar 06, 2026
133.49M-0.53%
Mar 05, 2026
134.20M-3.08%
Mar 04, 2026
138.46M+2.09%